What are the opening hours?

Monday 8am - 5pm Tuesday 8am - 5pm Wednesday 8am - 5pm Thursday 8am - 5pm Friday 8am - 5pm

ISPE

Follow our new page: https://www.facebook.com/profile.php?id=61556557244952

09/02/2026

Great careers are built through meaningful connections. The 2026 ISPE Annual Meeting & Expo brings together professionals from across the global life sciences community for more than just technical sessions.

From the Sunday Social and networking lunches to the Welcome Reception in the Expo Hall and the Tuesday Night Celebration, attendees can engage with peers, exchange ideas, and explore new opportunities alongside industry leaders.

Designed for professionals at every career stage, these experiences foster valuable conversations, professional growth, and lasting industry relationships.
Secure your spot at this premier gathering: https://bit.ly/46wdX0i

09/02/2026

As antibody-drug conjugates (ADCs) continue to transform cancer treatment, manufacturers face increasing pressure to deliver these highly complex therapies faster, more safely, and with greater reliability. Yet one of the industry's most persistent challenges remains the fragmented supply chain traditionally required to produce ADCs.

BSP Pharmaceuticals’ integrated ADC manufacturing facility in Latina, Italy, offers a compelling solution and has been recognized as a 2026 ISPE FOYA Category Winner in Supply Chain

Congratulations to BSP Pharmaceuticals on this well-deserved recognition. Read the full story on iSpeak: https://hubs.la/Q04vRST80

Be there when the spotlight shines. Get your ticket to the 2026 ISPE FOYA Banquet and Awards Celebration and find out who the overall winner will be: https://hubs.la/Q04vRzQh0

09/01/2026

Share your expertise, contribute to industry discussions, and connect with professionals from around the world by submitting a proposal for one or both of the opportunities below.

• 2027 ISPE Aseptic Conference | Accepting proposals through this Friday, 4 September
• 2027 ISPE Europe Annual Conference | Accepting proposals through Friday, 23 October

Submit your proposal now: https://bit.ly/4x60Rlp

08/28/2026

Real conversations. Real insight. Right when you need it. ISPE is launching a new Regulatory Insights Series, a recurring forum on the regulatory questions shaping pharmaceutical manufacturing. The series brings together regulators and industry leaders for live, one-on-one conversations.

The inaugural session takes on a topic that generates more uncertainty than almost any other in the advanced manufacturing space.

Thursday, 17 September | Navigating FDA's Advanced Manufacturing Engagement Landscape: Programs and Practical Considerations

FDA has built substantial infrastructure to support novel manufacturing technologies: CDER's Emerging Technology Program, CBER's Advanced Technologies Team, the FRAME initiative, and Advanced Manufacturing Technology designation.

Where do the boundaries fall between them, what constitutes a well-prepared initial engagement, and at what point in a development program that engagement is most productive? Teams frequently approach the agency later than would serve them, and often through the wrong channel.

This session addresses those practical questions directly and includes live Q&A. Learn more and register for this complimentary webinar: https://hubs.la/Q04vKQKF0

08/28/2026

The life sciences industry has spent a decade talking about digital transformation. The conversation is no longer about whether to transform, but about how to do it in a way that holds up technically, operationally, and in front of a regulator.

That shift in maturity is what the 2026 ISPE Pharma 4.0™ and Biopharma Conference, 10–11 December in Berlin, is built to address.

Hear from Lineke Pelleboer and Markus Zeitz, PhD as they explore this year's program. Read more in this iSpeak blog: https://hubs.ly/Q04vzr0r0

08/27/2026

As pharmaceutical manufacturers work to deliver increasingly complex therapies while improving efficiency, sustainability, and worker safety, facilities must evolve to support entirely new approaches to drug production. Chugai Pharma Manufacturing’s FJ3 Project demonstrates how innovative facility design can help overcome long-standing manufacturing limitations while accelerating patient access to next-generation medicines.

Located in Fujieda City, Shizuoka, Japan, the 112,900-square-foot facility has earned Honorable Mention recognition in the 2026 ISPE Facility of the Year Awards program.

Congratulations to Chugai Pharma Manufacturing on this well-deserved recognition. Read the full story on iSpeak: https://hubs.la/Q04tl5RR0

Be there when the spotlight shines. Get your ticket to the 2026 ISPE FOYA Banquet and Awards Celebration and find out who the overall winner will be: https://hubs.la/Q04tk_VV0

08/26/2026

As artificial intelligence becomes embedded in validation workflows, life sciences organizations face a governance gap that traditional validation frameworks were not designed to close. AI systems introduce non-deterministic outputs, model drift, data dependency risks, and opacity challenges that demand a structured, continuous approach to oversight — not a one-time compliance exercise.

Read more in this sponsored content from Kneat: https://hubs.la/Q04sGHkP0

08/26/2026

As the pharmaceutical workforce shifts toward digital, continuous, and personalized manufacturing, organizations face a major challenge: closing the skill gaps required to run these complex operations.

At the 2026 ISPE Annual Meeting & Expo, the “People, Capability, and the Workforce of Delivery” track will break down the strategies needed to build a high-performing, agile workforce.

Sessions will explore:
• New roles created by digital transformation and AI integration
• Best practices for human/AI collaboration on the factory floor
• Actionable strategies for addressing technical talent shortages
• Scalable development models that elevate organizational culture

View sessions and register now: https://hubs.la/Q04mHDFC0

08/24/2026

Many organizations continue to face challenges applying quality risk management (QRM) principles consistently and effectively across the pharmaceutical lifecycle. The ISPE Guide: Quality Risk Management was developed to address those gaps in practical implementation.

While QRM has been a foundational element of pharmaceutical quality since the publication of ICH Q9, its application continues to evolve. The ICH Q9(R1) revision was introduced to address key areas for improvement identified in industry practice, including subjectivity in risk assessments, appropriate levels of formality, clarity in risk-based decision-making, and management of product availability risks.

Preview the Guide and explore the first chapter now: https://hubs.la/Q04tYMWM0

08/21/2026

Operational excellence in life sciences and pharmaceutical industries does not begin at startup or end with maintenance. It is built across the entire asset lifecycle, where every phase – from design and construction to manufacturing, quality assurance, and regulatory compliance – must work together to deliver better business and patient outcomes. This alignment is essential not only for operational efficiency but also for ensuring products are safe, effective, and consistently meet the highest quality standards throughout their lifecycle.

In this webinar, industry leaders will discuss how pharmaceutical and life sciences organizations can move beyond fragmented systems and siloed data to create a connected, lifecycle-driven approach to asset intelligence.

Learn more and register for this complimentary webinar: https://hubs.la/Q04ttgJP0

Address

600 N West Shore Boulevard
Tampa, FL
33609

Opening Hours

Monday	8am - 5pm
Tuesday	8am - 5pm
Wednesday	8am - 5pm
Thursday	8am - 5pm
Friday	8am - 5pm

Telephone

+18139602105

Website

https://www.ispe.org/contact-us

Alerts

Be the first to know and let us send you an email when ISPE posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Organization

Send a message to ISPE:

Want your organization to be the top-listed Non Profit Organization in Tampa?